| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 727534 | 84710 | PARACETAMOL MABO-FARMA 1 G COMPRIMIDOS EFG | PARACETAMOL MABO-FARMA 1 G COMPRIMIDOS EFG, 40 comprimidos (Blister PVC/Al) | 1000 mg | 5 | 40 | 10 | 40 comprimidos (Blister PVC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84710/84710_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84710/84710_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 0 | 2020-03-03 | View Edit Delete | ||||||||||||
| 727277 | 1191399001 | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | XOSPATA 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 84 comprimidos | 40 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191399001/1191399001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191399001/1191399001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2023-05-12 | View Edit Delete | ||||||||||||
| 727061 | 1191389001 | EPIDYOLEX 100 MG/ML SOLUCION ORAL | EPIDYOLEX 100 MG/ML SOLUCION ORAL, 1 frasco de 100 ml | 100 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191389001/1191389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191389001/1191389001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 35481 | JAZZ PHARMACEUTICALS IBERIA S.L. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2021-08-03 | View Edit Delete | ||||||||||||
| 727521 | 9454504IP3 | DIPROGENTA 0,5 MG/G + 1 MG/G CREMA | DIPROGENTA 0,5 MG/G + 1 MG/G CREMA, 1 tubo de 30 g | 0,5 mg/g + 1 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46755 | ECOFAR PRODUCTOS S.L. | 2019-12-05 | 1 | 1 | 1 | 2019-12-06 | 2019-12-05 | 1 | 2019-12-11 | View Edit Delete | ||||||||||||
| 726569 | 84423 | DEXULAC 80 MG/G BARNIZ DE UÑAS MEDICAMENTOSO | DEXULAC 80 MG/G BARNIZ DE UÑAS MEDICAMENTOSO, 1 frasco de 7 ml | 80 mg/g | 6 | 7 | 26 | 1 frasco de 7 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84423/84423_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84423/84423_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-02 | 2019-12-02 | 1 | 2022-07-29 | View Edit Delete | ||||||||||||
| 726401 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 2,5 ml | 74 MBq/ml inyectable 2,5 ml | 45 | 1 | 34 | 1 vial de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 726402 | 1191372001 | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG | STRIASCAN 74 MBQ/ML SOLUCION INYECTABLE EFG, 1 vial de 5 ml | 74 MBq/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191372001/1191372001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191372001/1191372001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 689 | CURIUM PHARMA SPAIN S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-03-24 | View Edit Delete | ||||||||||||
| 727472 | 84689 | LETROZOL MABO 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LETROZOL MABO 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister Al-PVC/PE/PVDC) | 2,5 mg | 5 | 30 | 10 | 30 comprimidos (Blister Al-PVC/PE/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84689/84689_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84689/84689_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2020-09-15 | View Edit Delete | ||||||||||||
| 727478 | 3400935437068IP2 | CELEBREX 200 MG CAPSULAS DURAS | CELEBREX 200 MG CAPSULAS DURAS, 30 cápsulas | 200 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3400935437068IP2/3400935437068IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44008 | ECOFAR PRODUCTOS S.L. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727474 | 84690 | DEKRISTOLAN 20.000 UI CAPSULAS BLANDAS | DEKRISTOLAN 20.000 UI CAPSULAS BLANDAS 4 cápsulas | 20.000 UI | 5 | 4 | 43 | 4 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84690/84690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84690/84690_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71281 | MIBE PHARMA ESPAÑA S.L.U. | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2021-06-01 | View Edit Delete | ||||||||||||
| 727516 | 84701 | POSACONAZOL GLENMARK 40 MG/ML SUSPENSION ORAL EFG | POSACONAZOL GLENMARK 40 MG/ML SUSPENSION ORAL EFG, 1 frasco de 105 ml | 40 mg/ml | 6 | 105 | 26 | 1 frasco de 105 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84701/84701_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84701/84701_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2019-12-02 | 1 | 1 | 1 | 2019-12-03 | 2019-12-02 | 1 | 2020-04-15 | View Edit Delete | ||||||||||||
| 726758 | 1181264011 | ALUNBRIG 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264011/1181264011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264011/1181264011_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726797 | 1181264008 | ALUNBRIG 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 90 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 90 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264008/1181264008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264008/1181264008_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726798 | 1181264010 | ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 180 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 180 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264010/1181264010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264010/1181264010_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 726799 | 1181264012 | ALUNBRIG 90MG + 180MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ALUNBRIG 90MG + 180MG COMPRIMIDOS RECUBIERTOS CON PELICULA Envase de inicio: 28 comprimidos (7 x 90 mg + 21 x 180 mg) | 90 mg + 180 mg | 5 | 28 | 10 | Envase de inicio: 28 comprimidos (7 x 90 mg + 21 x 180 mg) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181264012/1181264012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181264012/1181264012_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-04-15 | View Edit Delete | ||||||||||||
| 727446 | 84677 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/10 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84677/84677_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84677/84677_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 727447 | 84678 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84678/84678_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84678/84678_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 727448 | 84679 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84679/84679_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84679/84679_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 727449 | 84680 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 40 MG/5 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84680/84680_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84680/84680_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-07-02 | View Edit Delete | ||||||||||||
| 727450 | 84681 | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA CINFA 20 MG/5 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84681/84681_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84681/84681_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2019-11-28 | 1 | 1 | 1 | 2019-11-29 | 2019-11-28 | 1 | 2021-07-02 | View Edit Delete |
Page 277 of 1036, showing 20 records out of 20703 total, starting on record 5521, ending on 5540